Medicine & Life Sciences
Abiraterone Acetate
8%
Adenocarcinoma
8%
Androgen Receptors
12%
Androgens
20%
Apoptosis
7%
Bacteriophages
11%
Biomarkers
11%
Bone and Bones
13%
Bone Neoplasms
9%
Breast Neoplasms
5%
cabozantinib
9%
Carcinogenesis
6%
Carcinoma
23%
Castration
28%
Caveolin 1
10%
CCAAT-Binding Factor
8%
Cell Line
12%
Chromosomes
5%
Cisplatin
9%
Clear-cell metastatic renal cell carcinoma
5%
Clinical Trials
9%
Colorectal Neoplasms
5%
Confidence Intervals
8%
Disease Progression
5%
DNA
7%
Docetaxel
9%
Doxorubicin
8%
Drug Therapy
22%
Endothelial Cells
6%
Everolimus
7%
gemcitabine
5%
Gene Expression
6%
Genes
15%
Genetic Therapy
6%
Genome
5%
Germ Cell and Embryonal Neoplasms
7%
Growth
13%
Heterografts
8%
Immunotherapy
16%
In Vitro Techniques
6%
Integrins
6%
Interferons
7%
Ipilimumab
13%
Kidney
7%
Kidney Neoplasms
10%
Ligands
12%
Lymph Nodes
5%
MDV 3100
6%
Melanoma
7%
Mutation
11%
Neoplasm Metastasis
27%
Neoplasms
68%
Nephrectomy
7%
Nivolumab
17%
Nonseminomatous germ cell tumor
5%
Nude Mice
5%
pazopanib
5%
pembrolizumab
5%
Peptides
9%
Phenotype
6%
Prednisone
5%
Progression-Free Survival
11%
Prostate
23%
Prostate-Specific Antigen
11%
Prostatectomy
5%
Prostatic Neoplasms
100%
Protein-Tyrosine Kinases
7%
Proteins
10%
Radiotherapy
5%
Recurrence
8%
Renal Cell Carcinoma
69%
Retinoblastoma
11%
Safety
7%
Serum
5%
Small Cell Carcinoma
5%
src-Family Kinases
7%
Sunitinib
14%
Survival
25%
T-Lymphocytes
9%
Testicular Neoplasms
5%
Therapeutics
28%
Transitional Cell Carcinoma
5%
Tumor Microenvironment
9%
Urinary Bladder
9%
Urinary Bladder Neoplasms
25%
Vascular Endothelial Growth Factor A
7%
von Hippel-Lindau Disease
5%
Watchful Waiting
5%